trihexyphenidyl has been researched along with Rett Syndrome in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Rett Syndrome: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gika, AD | 1 |
| Hughes, E | 1 |
| Goyal, S | 1 |
| Sparkes, M | 1 |
| Lin, JP | 1 |
1 other study available for trihexyphenidyl and Rett Syndrome
| Article | Year |
|---|---|
Trihexyphenidyl for acute life-threatening episodes due to a dystonic movement disorder in Rett syndrome.
Topics: Adolescent; Antiparkinson Agents; Child; Dystonic Disorders; Electrocardiography; Electroencephalogr | 2010 |